Trial of Computerized MET for Adolescent Substance Use
- Conditions
- Drug AbuseAlcohol AbuseNicotine Dependence
- Interventions
- Behavioral: METBehavioral: iMET
- Registration Number
- NCT01784653
- Lead Sponsor
- Boston Children's Hospital
- Brief Summary
The purpose of this study is to test the effects of a computerized, self-directed Motivational Enhancement Therapy program for adolescent substance use (iMET), in comparison to clinician-delivered MET and Treatment As Usual (TAU), on treatment engagement and substance use. The investigators hypothesize that both iMET and MET will be more effective than TAU in engaging/retaining patients in treatment and in reducing substance use during a 12-month follow-up period. The investigators also hypothesize that Self-directed iMET will be as effective as the clinician-guided MET in increasing treatment engagement and abstinence during the 12-months follow-up period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- completed initial visit at the treatment program;
- be available to return for iMET/MET sessions (if assigned)
- be available to complete all follow-up measurements
- a past-12-month CRAFFT score >1
- have used substances on >6 days (not including tobacco use) during the 90 days preceding their visit
- unable to speak and understand English, or read English at a 5th grade reading level
- youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MET MET Clinician-delivered Motivational Enhancement Therapy iMET iMET Participants will complete a self-guided computerized Motivational Enhancement Therapy
- Primary Outcome Measures
Name Time Method Treatment engagement 12 months We will compare the number of individual visits in the program, the number of group sessions completed, and the number of urine screens completed during a 12 month follow-up period by each participant in the three study arms.
- Secondary Outcome Measures
Name Time Method Days abstinent past-90-days We will calculate the past-90-days number of days abstinent from any substance use and from the primary substance and the number of weeks abstinent from any substance use.
Driving/Riding Risk past-90-days We will compare group trends in prevalence and frequency of past-90-days Driving while impaired or Riding with an impaired driver.
HIV Risk Behavior past-90-days We will compare group trends in prevalence and frequency of past-90-days HIV Risk Behaviors.
Trial Locations
- Locations (1)
Boston Children's Hospital
🇺🇸Boston, Massachusetts, United States